MARK SHEPTOFF FINANCIAL PLANNING, LLC
Position in AMRX — Amneal Pharmaceuticals, Inc.
CIK 1607355
GLASTONBURY, CT
Position in AMRX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$6,215
-$85 QoQ
Shares Held
500
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MARK SHEPTOFF FINANCIAL PLANNING, LLC holds $870,358 across 7 Drug Manufacturers - Specialty & Generic names. AMRX ranks #4 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
16,500 | $794,475 | |
| 2 | ZTS |
Zoetis Inc.
|
380 | $44,919 | |
| 3 | VTRS |
Viatris Inc
|
1,598 | $21,588 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
500 | $6,215 | |
| 5 | CURLF |
Curaleaf Holdings, Inc.
|
800 | $1,712 | |
| 6 | CGC |
Canopy Growth Corp
|
1,500 | $1,423 | |
| 7 | ACB |
Aurora Cannabis Inc
|
8 | $26 |
All Filings in AMRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,215 | 500 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $6,300 | 500 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||